{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:05:10Z","timestamp":1793397910277,"version":"4.5.0"},"reference-count":76,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec id=\"ab-ysc260003-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>In the US, 5% to 6% of pregnant patients are treated with selective serotonin reuptake inhibitors (SSRI), primarily for major depressive disorder (MDD), which has a prevalence of about 12%. Psychiatric conditions are a leading cause of maternal morbidity and mortality. MDD is a common disorder that must be treated during pregnancy to improve outcomes for the mother, infant, family, and community.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ysc260003-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>MDD is a complex, multifactorial brain disease arising from genetic, environmental, and epigenetic factors. Factors unique to the perinatal period are associated with additional pathophysiologic changes specific to MDD. Maternal stress and psychiatric illnesses adversely affect fetal and infant outcomes. SSRI are an essential component of perinatal mental health care. Studies that define the benefits of SSRI treatment in pregnancy are fewer than those defining risks; however, several describe adverse effects with drug discontinuation in women with moderate to severe MDD. Evaluating the safety of SSRI treatment during pregnancy has been challenging due to the potential for confounding in observational studies by the underlying indication and associated factors. Once the impact of the drug is disentangled from that of MDD and its sequelae, accumulated evidence suggests that SSRI carry little or no risk for serious adverse outcomes. The thrust of the field has shifted to prioritize treatment of MDD to optimize maternal health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ysc260003-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Meaningful advances in the treatment of perinatal MDD require coordinated attention to multiple aspects of clinical care delivery and research, informed by a perspective accounting for the health needs of 2 generations. Expanding access to care\u2014particularly in maternity, child health, and psychiatric care deserts\u2014is a public health imperative. A structured decision-making process facilitates the provision of balanced information on the potential maternal and fetal risks of untreated or undertreated illness, the benefits of treatment, and the risks associated with SSRI exposure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2026.2405","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:00:34Z","timestamp":1786546834000},"page":"1062","source":"Crossref","is-referenced-by-count":1,"title":["Depression and SSRI Treatment During Pregnancy\u2014Prioritizing Maternal Mental Health"],"prefix":"10.1001","volume":"83","author":[{"given":"Katherine L.","family":"Wisner","sequence":"first","affiliation":[{"name":"Departments of Psychiatry and Pediatrics, Developing Brain Institute, Children\u2019s National Hospital, and Obstetrics and Gynecology, George Washington University School of Medicine, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim F.","family":"Oberlander","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and School of Population and Public Health, University of British Columbia and BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Osborne","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology and Psychiatry, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista F.","family":"Huybrechts","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"ysc260003r2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jad.2019.12.014","article-title":"The international prevalence of antidepressant use before, during, and after pregnancy: a systematic review and meta-analysis of timing, type of prescriptions and geographical variability.","volume":"264","author":"Molenaar","year":"2020","journal-title":"J Affect Disord"},{"issue":"1-3","key":"ysc260003r3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jad.2011.07.004","article-title":"Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States.","volume":"135","author":"Le Strat","year":"2011","journal-title":"J Affect Disord"},{"issue":"5","key":"ysc260003r4","first-page":"256","article-title":"The genetics of major depressive disorder: current insights.","volume":"7","author":"Dean","year":"2024","journal-title":"Neuroscience and Psychiatry: Open Access"},{"key":"ysc260003r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2025.102855","article-title":"The neurobiology of major depressive disorder: updates and perspectives from proteomics.","volume":"255","author":"Spero","year":"2025","journal-title":"Prog Neurobiol"},{"issue":"7","key":"ysc260003r6","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/s41591-024-03057-9","article-title":"Personalized brain circuit scores identify clinically distinct biotypes in depression and anxiety.","volume":"30","author":"Tozzi","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"ysc260003r7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/ijms27031267","article-title":"Neurochemical and energetic alterations in depression: a narrative review of potential PET biomarkers.","volume":"27","author":"Cornejo Schmiedl","year":"2026","journal-title":"Int J Mol Sci"},{"key":"ysc260003r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2024.111846","article-title":"Magnetic resonance imaging connectivity features associated with response to transcranial magnetic stimulation in major depressive disorder.","volume":"342","author":"Briley","year":"2024","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"12","key":"ysc260003r9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0322090","article-title":"Effect of depression and serotonin reuptake inhibitors antidepressant treatment during pregnancy on protein expression in the human placenta: a quantitative proteomics analysis.","volume":"20","author":"Ok","year":"2025","journal-title":"PLoS One"},{"key":"ysc260003r10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.yfrne.2018.12.001","article-title":"Pathophysiological mechanisms implicated in postpartum depression.","volume":"52","author":"Payne","year":"2019","journal-title":"Front Neuroendocrinol"},{"issue":"12","key":"ysc260003r11","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1038\/s41380-025-03227-2","article-title":"Neural correlates of peripartum depression: a systematic review, meta-analysis and comparison to major depressive disorder.","volume":"30","author":"Sobral","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"1","key":"ysc260003r12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/19585969.2023.2262464","article-title":"Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression.","volume":"25","author":"Carlini","year":"2023","journal-title":"Dialogues Clin Neurosci"},{"issue":"2","key":"ysc260003r13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1017\/S0954579414000029","article-title":"The persisting effect of maternal mood in pregnancy on childhood psychopathology.","volume":"26","author":"O\u2019Donnell","year":"2014","journal-title":"Dev Psychopathol"},{"issue":"5","key":"ysc260003r14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jamapsychiatry.2023.5648","article-title":"Prioritizing maternal mental health in addressing morbidity and mortality.","volume":"81","author":"Wisner","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"ysc260003r15","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1377\/hlthaff.2021.00801","article-title":"Meta-analysis of antenatal depression and adverse birth outcomes in US populations, 2010-20.","volume":"40","author":"Simonovich","year":"2021","journal-title":"Health Aff (Millwood)"},{"issue":"11","key":"ysc260003r16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S2215-0366(25)00271-8","article-title":"Association between hyperemesis gravidarum and depression: a national register-based controlled study in Finland.","volume":"12","author":"Ter\u00e4v\u00e4-Utti","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"ysc260003r17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0029-7844(99)00602-X","article-title":"Depression and anxiety in early pregnancy and risk for preeclampsia.","volume":"95","author":"Kurki","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"11","key":"ysc260003r18","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.146","article-title":"Alterations in amygdala-prefrontal circuits in infants exposed to prenatal maternal depression.","volume":"6","author":"Posner","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"1","key":"ysc260003r19","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/s41598-021-81681-y","article-title":"Maternal stress during pregnancy alters fetal cortico-cerebellar connectivity in utero and increases child sleep problems after birth.","volume":"11","author":"van den Heuvel","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"ysc260003r20","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jaac.2022.03.021","article-title":"Associations of maternal prenatal stress and depressive symptoms with childhood neurobehavioral outcomes in the ECHO cohort of the NICHD fetal growth studies: fetal growth velocity as a potential mediator.","volume":"61","author":"Babineau","year":"2022","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"ysc260003r21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jaac.2023.08.018","article-title":"Independent prediction of child psychiatric symptoms by maternal mental health and child polygenic risk scores.","volume":"63","author":"Chen","year":"2024","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"ysc260003r22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.19940","article-title":"Association of prenatal maternal psychological distress with fetal brain growth, metabolism, and cortical maturation.","volume":"3","author":"Wu","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"7","key":"ysc260003r23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/dev.20549","article-title":"Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming.","volume":"53","author":"Ponder","year":"2011","journal-title":"Dev Psychobiol"},{"issue":"6","key":"ysc260003r25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ame2.12284","article-title":"Could a phase model help to improve translational animal research?","volume":"5","author":"Mayer","year":"2022","journal-title":"Animal Model Exp Med"},{"issue":"7","key":"ysc260003r26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/ijnp\/pyy037","article-title":"Relevance of rodent models of depression in clinical practice: can we overcome the obstacles in translational neuropsychiatry?","volume":"21","author":"S\u00f6derlund","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"ysc260003r27","doi-asserted-by":"publisher","first-page":"22852","DOI":"10.1038\/s41598-021-02074-9","article-title":"Tianeptine, but not fluoxetine, decreases avoidant behavior in a mouse model of early developmental exposure to fluoxetine.","volume":"11","author":"Pekarskaya","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"ysc260003r28","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1021\/acschemneuro.9b00180","article-title":"In utero exposure to citalopram mitigates maternal stress effects on fetal brain development.","volume":"10","author":"Velasquez","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"ysc260003r29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10928-020-09685-1","article-title":"Enabling pregnant women and their physicians to make informed medication decisions using artificial intelligence.","volume":"47","author":"Davidson","year":"2020","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"2","key":"ysc260003r31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1176\/appi.prcp.20210034","article-title":"Trajectories of depressive and anxiety symptoms across pregnancy and postpartum in selective serotonin reuptake inhibitor-treated women.","volume":"4","author":"Mesches","year":"2022","journal-title":"Psychiatr Res Clin Pract"},{"issue":"5","key":"ysc260003r32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jamapsychiatry.2013.87","article-title":"Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings.","volume":"70","author":"Wisner","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"ysc260003r33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/15409996261418118","article-title":"Social determinants of health associated with perinatal health outcomes in different racial\/ethnic groups: a narrative review of reviews.","volume":"35","author":"Gyan","year":"2026","journal-title":"J Womens Health (Larchmt)"},{"issue":"26","key":"ysc260003r34","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.","volume":"356","author":"Louik","year":"2007","journal-title":"N Engl J Med"},{"issue":"26","key":"ysc260003r35","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.","volume":"356","author":"Alwan","year":"2007","journal-title":"N Engl J Med"},{"issue":"25","key":"ysc260003r36","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects.","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"ysc260003r37","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/jamainternmed.2022.4268","article-title":"Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children.","volume":"182","author":"Suarez","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"12","key":"ysc260003r38","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2020.2453","article-title":"Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects.","volume":"77","author":"Anderson","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"21","key":"ysc260003r39","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1056\/NEJMp2511434","article-title":"Untangling the risks of antidepressants in pregnancy.","volume":"393","author":"Huybrechts","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"ysc260003r40","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1186\/s12888-025-07462-3","article-title":"Different psychological interventions for perinatal depression: a systematic review and meta-analysis of randomized controlled trials.","volume":"25","author":"Hua","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"4","key":"ysc260003r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2025.152076","article-title":"Perinatal psychiatry: balancing maternal-fetal exposures to mental disorders and drug treatments.","volume":"49","author":"Nielsen","year":"2025","journal-title":"Semin Perinatol"},{"issue":"4","key":"ysc260003r42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004363.pub3","article-title":"Antidepressants for preventing postnatal depression.","volume":"4","author":"Molyneaux","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"ysc260003r43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.295.5.499","article-title":"Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.","volume":"295","author":"Cohen","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"ysc260003r44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003895","article-title":"Antidepressant discontinuation before or during pregnancy and risk of psychiatric emergency in Denmark: a population-based propensity score-matched cohort study.","volume":"19","author":"Liu","year":"2022","journal-title":"PLoS Med"},{"issue":"6","key":"ysc260003r45","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/EDE.0b013e3182306847","article-title":"Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?","volume":"22","author":"Yonkers","year":"2011","journal-title":"Epidemiology"},{"issue":"4","key":"ysc260003r46","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19r13134","article-title":"The risk of relapse of depression during pregnancy after discontinuation of antidepressants: a systematic review and meta-analysis.","volume":"81","author":"Bayrampour","year":"2020","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"ysc260003r47","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2026.0196","article-title":"Lasting income costs of mental and physical illness.","volume":"7","author":"Johnson","year":"2026","journal-title":"JAMA Health Forum"},{"issue":"4","key":"ysc260003r48","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/AOG.0000000000000447","article-title":"Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage.","volume":"124","author":"Andersen","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"ysc260003r49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1176\/appi.ajp.2012.11081251","article-title":"SSRI use during pregnancy and risk of stillbirth and neonatal mortality.","volume":"170","author":"Jimenez-Solem","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"9","key":"ysc260003r50","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/jp.2017.92","article-title":"Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study.","volume":"37","author":"Venkatesh","year":"2017","journal-title":"J Perinatol"},{"issue":"21","key":"ysc260003r51","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/jama.2015.5605","article-title":"Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.","volume":"313","author":"Huybrechts","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"ysc260003r52","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/1471-0528.16586","article-title":"Re: SSRI use during pregnancy and risk for postpartum haemorrhage: a national register-based cohort study in Sweden: this registry-based large study of postpartum haemorrhage with SSRI usage, despite crucial limitations, shows any increased risk to be reassuringly low and clinically non-significant.","volume":"128","author":"Sholapurkar","year":"2021","journal-title":"BJOG"},{"issue":"3","key":"ysc260003r53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092778","article-title":"Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.","volume":"9","author":"Huybrechts","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"ysc260003r54","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1176\/appi.ajp.2015.14121575","article-title":"Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data.","volume":"172","author":"Malm","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"5","key":"ysc260003r55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000516031","article-title":"Neonatal withdrawal syndrome following late in utero exposure to selective serotonin reuptake inhibitors: a systematic review and meta-analysis of observational studies.","volume":"90","author":"Wang","year":"2021","journal-title":"Psychother Psychosom"},{"issue":"5","key":"ysc260003r56","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0181","article-title":"Neonatal morbidity after maternal use of antidepressant drugs during pregnancy.","volume":"138","author":"N\u00f6rby","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"ysc260003r57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.13367","article-title":"Neonatal outcome and adaption after in utero exposure to antidepressants: a systematic review and meta-analysis.","volume":"145","author":"Kautzky","year":"2022","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"ysc260003r58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1176\/appi.ajp.2015.14080989","article-title":"The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month.","volume":"173","author":"Salisbury","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"16","key":"ysc260003r59","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.3390\/ijerph20166565","article-title":"Consensus panel recommendations for the pharmacological management of pregnant women with depressive disorders.","volume":"20","author":"Eleftheriou","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"ysc260003r60","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/14767050701209560","article-title":"Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? a critical review of the literature.","volume":"20","author":"Alder","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ysc260003r61","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuroscience.2015.09.001","article-title":"Untreated depression during pregnancy: short- and long-term effects in offspring. a systematic review.","volume":"342","author":"Gentile","year":"2017","journal-title":"Neuroscience"},{"issue":"12","key":"ysc260003r62","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1001\/jamapsychiatry.2023.3161","article-title":"Prenatal antidepressant exposure and offspring brain morphologic trajectory.","volume":"80","author":"Koc","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"ysc260003r63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bpsgos.2022.02.005","article-title":"Prenatal selective serotonin reuptake inhibitor exposure, depression, and brain morphology in middle childhood: results from the ABCD study.","volume":"3","author":"Moreau","year":"2022","journal-title":"Biol Psychiatry Glob Open Sci"},{"issue":"12","key":"ysc260003r64","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1001\/jamapsychiatry.2023.2664","article-title":"Maternal depression, prenatal SSRI exposure, and brain trajectories in childhood.","volume":"80","author":"Talati","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"ysc260003r65","doi-asserted-by":"publisher","first-page":"j3668","DOI":"10.1136\/bmj.j3668","article-title":"Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study.","volume":"358","author":"Liu","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"ysc260003r66","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jaac.2025.03.026","article-title":"Prenatal antidepressant exposure and risk of depression and anxiety disorders: an electronic health records-based cohort study.","volume":"65","author":"Talati","year":"2026","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"ysc260003r67","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2022.623","article-title":"Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study.","volume":"9","author":"Hutchison","year":"2023","journal-title":"BJPsych Open"},{"issue":"8","key":"ysc260003r68","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41386-021-01005-6","article-title":"Long-term prenatal effects of antidepressant use on the risk of affective disorders in the offspring: a register-based cohort study.","volume":"46","author":"Rommel","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"ysc260003r69","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":"Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"ysc260003r70","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1176\/appi.ajp.157.12.1933","article-title":"Risk-benefit decision making for treatment of depression during pregnancy.","volume":"157","author":"Wisner","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"6","key":"ysc260003r71","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/07067437241303031","article-title":"Canadian Network for Mood and Anxiety Treatments 2024 clinical practice guideline for the management of perinatal mood, anxiety, and related disorders: guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l\u2019humeur, des troubles anxieux et des troubles connexes p\u00e9rinatals.","volume":"70","author":"Vigod","year":"2025","journal-title":"Can J Psychiatry"},{"issue":"6","key":"ysc260003r72","doi-asserted-by":"publisher","DOI":"10.1002\/bdr2.2496","article-title":"Synthesizing cohort study results to promote knowledge transfer of safety data regarding gestational antidepressant exposure and offspring congenital anomalies: a test of concept.","volume":"117","author":"Moses-Kolko","year":"2025","journal-title":"Birth Defects Res"},{"issue":"5","key":"ysc260003r73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.295.5.499","article-title":"Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.","volume":"295","author":"Cohen","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"ysc260003r74","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41398-021-01638-7","article-title":"The effectiveness of enhanced evidence-based care for depressive disorders: a meta-analysis of randomized controlled trials.","volume":"11","author":"Xiao","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"6","key":"ysc260003r75","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/cpt.2746","article-title":"Changes in sertraline plasma concentrations across pregnancy and postpartum.","volume":"112","author":"Stika","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"ysc260003r76","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/YIC.0000000000000520","article-title":"Relevance of pharmacogenetic analyses and therapeutic drug monitoring of antidepressants for an individualized treatment of peripartum psychopathology.","volume":"39","author":"Colombo","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"key":"ysc260003r24","volume-title":"Advancing Clinical Research with Pregnant and Lactating Populations: Overcoming Real and Perceived Liability Risks","author":"National Academies of Sciences, Engineering, and Medicine","year":"2024"},{"key":"ysc260003r1","unstructured":"US Food and Drug Administration. FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy. YouTube. https:\/\/www.youtube.com\/watch?v=2Nha1Zh63SA"},{"key":"ysc260003r30","unstructured":"Lewkowitz? AK, Miller? ES. Getting the facts straight: pregnancy, depression, and SSRIs. September 3, 2025. Accessed July 7, 2026. https:\/\/www.smfm.org\/news\/getting-the-facts-straight--pregnancy-depression-and-ssris"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2852348\/jamapsychiatry_wisner_2026_sc_260003_1790709508.7354.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:01:01Z","timestamp":1791385261000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2852348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.2405","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}